Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.
Press releases published on May 20, 2025

Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"
Latest developments expand Predictive’s AI-driven drug discovery platform to include biomarker discovery and drug repurposing With the global biomarker discovery market valued at $14.5 billion in 2024 and projected to grow at a 19.4% CAGR through 2030, …

Natural Remedies Introduces Ashwa.30, a Next-Gen Ashwagandha for Energy, Endurance and Stress Support
BANGALORE, India, May 20, 2025 (GLOBE NEWSWIRE) -- Natural Remedies, a global leader in botanical branded ingredients, announces the launch of Ashwa.30, a next-generation ashwagandha extract designed to improve energy, boost endurance, and support stress …

IO Biotech Announces Participation in Cowen 6th Annual Oncology Innovation Summit and Jefferies Global Healthcare Conference
NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, announced today that Mai-Britt Zocca, PhD, the company’s …

Mersana Therapeutics to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass., May 20, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, …

Marker Therapeutics Reports that Lymphodepletion Improves the Expansion and Persistence of Multi-Antigen Recognizing T Cells in Patients with Lymphoma
Preconditioning with lymphodepletion linked to stronger MAR-T cells response and suggests enhanced anti-tumor activity Highest enrollment since study launch underscores momentum and signals a positive trial trajectory Clinical data readout from Phase 1 …

中国患者越来越多的JY整形外科皮肤科扩大韩中美容医疗交流
对Ulthera·钛提拉术、皮肤助推器等高功能施术的需求增加 继中国医疗团队访问之后, 正式开始交流, 确认K-美容的地位 SEOUL, GANGNAM, SOUTH KOREA, May 20, 2025 /EINPresswire.com/ -- 位于首尔清潭洞的JY整形外科皮肤科继中国医疗团队的正式访问之后, 当地患者也接连访问, 作为韩中美容医疗交流的中心备受关注。 据JY整形外科皮肤科透露, 最近中国患者的访问次数不断增加, 特别是对Ulthera …

Resonance of the Soul - Flowers & Harmonics—A Poetic Journey by Dr. Ivan Edwards
Dr. Ivan Edwards unveils a powerful anthology of poetry that speaks to the soul, coming soon to Amazon. SAN ANTONIO, TX, UNITED STATES, May 19, 2025 /EINPresswire.com/ -- Dr. Ivan Edwards Announces Upcoming Poetry Anthology—"Resonance of the Soul: …

Philips launches RADIQAL study to generate real-world evidence for new ultra-low X-ray dose technology in coronary procedures
May 20, 2025 Prospective, randomized, unblinded, comparative, international, multi-center clinical investigation 824 patients across 6 hospitals in Spain, Czech Republic, Denmark and the US Primary objective is to demonstrate that the new technology can …

Reflect Scientific Receives Over $250,000 in New Orders for High-Performance Freezers from International Biotech and Pharma Clients
OREM, Utah, May 20, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of advanced cryogenic and refrigeration technologies, announced today it has received over $250,000 in new orders for its high-performance freezer systems. The …

MBX Biosciences to Participate in June Investor Conferences
CARMEL, Ind., May 20, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic …

Aligos Therapeutics Appoints Laura Kavanaugh as Vice President, Head of Legal
SOUTH SAN FRANCISCO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …

Reviva to Participate in Upcoming Investor Conferences in May 2025
CUPERTINO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central …

Medela Introduces Magic InBra™ With FluidFeel Technology™—Where Science Meets Uncompromising Care
Baar, Switzerland, May 20, 2025 (GLOBE NEWSWIRE) -- Research-Driven Innovation Highlights: FluidFeel Technology™: Developed through extensive lactation research, this feature creates an optimized pumping environment by allowing warm milk circulation …

Enlivex Selected to Present at Israeli BioMed 2025 Conference
Presentation to highlight Allocetra™ and the therapeutic potential of macrophage reprogramming in inflammatory diseases Ness-Ziona, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage …

Devereux Georgia expands foster care services to Savannah
KENNESAW, Ga., May 20, 2025 (GLOBE NEWSWIRE) -- Devereux Advanced Behavioral Health Georgia today announced it is now serving the Savannah, Georgia, foster care community, expanding its reach to provide critical care, support and stability for youth and …

Frame and Labcorp Collaborate to Expand Access to Fertility Care and Testing Services
SAN FRANCISCO, May 20, 2025 (GLOBE NEWSWIRE) -- Frame, the collaborative care platform transforming access to reproductive and fertility care, today announced a strategic collaboration with Labcorp, a global leader of innovative and comprehensive …

Altais and Autonomize AI Partner to Reduce Administrative Burden and Empower Clinical Teams
AUSTIN, Texas, and OAKLAND, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Altais and Autonomize AI today announced a strategic partnership aimed at reducing the rising administrative burden on care management and clinical quality teams. Altais will introduce …

Beyond Air Schedules Fiscal Year End 2025 Financial Results Conference Call and Webcast
GARDEN CITY, N.Y., May 20, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives …

Health Catalyst to Participate in Upcoming Investor Conferences
SALT LAKE CITY, May 20, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Jason Alger, Chief Financial …

SELLAS Life Sciences to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase
NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …